Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 2266 AL 2280

Seed amplification and RT-QuIC assays to investigate protein seed structures and strains

Standke HG, Kraus A.

Cell Tissue Res. 2023 Apr;392(1):323-335. doi: 10.1007/s00441-022-03595-z. Epub 2022 Mar 8.

Predictors and correlates of emotionalism across acquired and progressive neurological conditions: A systematic review

Fitzgerald S, Gracey F, Trigg E, Broomfield N.

Neuropsychol Rehabil. 2023 Jun;33(5):945-987. doi: 10.1080/09602011.2022.2052326. Epub 2022 Mar 24.

Unmet needs in the diagnosis and treatment of Parkinson's disease psychosis and dementia-related psychosis

Sabbagh M, Small GW, Isaacson SH, Torres-Yaghi Y, Pagan F, Pahwa R.

Int J Psychiatry Clin Pract. 2023 Mar;27(1):69-81. doi: 10.1080/13651501.2022.2058406. Epub 2022 May 14.

Macromolecular Structures and Proteins Interacting with the Microtubule Associated Tau Protein

Jiménez JS.

Neuroscience. 2023 May 10;518:70-82. doi: 10.1016/j.neuroscience.2022.05.023. Epub 2022 May 21.

Recent advances in Lewy body dementia: A comprehensive review

Prasad S, Katta MR, Abhishek S, Sridhar R, Valisekka SS, Hameed M, Kaur J, Walia N.

Dis Mon. 2023 May;69(5):101441. doi: 10.1016/j.disamonth.2022.101441. Epub 2022 Jun 9.

Seeing the Woods for the Trees? Applying Diagnostic Criteria for Dementia with Lewy Bodies to Patients Presenting with Posterior Cortical Atrophy

Kelly MJ, Fearon C, O'Dowd S.

Alzheimer Dis Assoc Disord. 2023 Jan-Mar 01;37(1):88-91. doi: 10.1097/WAD.0000000000000522. Epub 2022 Aug 4.

The Association Between Somatic Symptom Disorders and Neurocognitive Disorders: A Systematic Review

Sammartino-Arbour A, Dufour A, Frenette V, Forget MF, Bruneau MA, Ducharme S, Camicioli R, Nguyen QD, Desmarais P.

Am J Geriatr Psychiatry. 2023 Jan;31(1):33-43. doi: 10.1016/j.jagp.2022.07.007. Epub 2022 Jul 24.

Advanced molecular therapies for neurological diseases: focus on stroke, alzheimer's disease, and parkinson's disease

Katta M, Mathew BA, Chaturvedi P, Ludhiadch A, Munshi A.

Neurol Sci. 2023 Jan;44(1):19-36. doi: 10.1007/s10072-022-06356-6. Epub 2022 Sep 6.

Mechanisms of prion-induced toxicity

Mercer RCC, Harris DA.

Cell Tissue Res. 2023 Apr;392(1):81-96. doi: 10.1007/s00441-022-03683-0. Epub 2022 Sep 7.

The regulatory mechanism and therapeutic potential of transcription factor EB in neurodegenerative diseases

Jiao F, Zhou B, Meng L.

CNS Neurosci Ther. 2023 Jan;29(1):37-59. doi: 10.1111/cns.13985. Epub 2022 Oct 2.

Retinal organoids from human-induced pluripotent stem cells: From studying retinal dystrophies to early diagnosis of Alzheimer's and Parkinson's disease

Móvio MI, de Lima-Vasconcellos TH, Dos Santos GB, Echeverry MB, Colombo E, Mattos LS, Resende RR, Kihara AH.

Semin Cell Dev Biol. 2023 Jul 30;144:77-86. doi: 10.1016/j.semcdb.2022.09.011. Epub 2022 Oct 7.

(Dis-)Connected Dots in Dementia with Lewy Bodies-A Systematic Review of Connectivity Studies

Habich A, Wahlund LO, Westman E, Dierks T, Ferreira D.

Mov Disord. 2023 Jan;38(1):4-15. doi: 10.1002/mds.29248. Epub 2022 Oct 17.

Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease

Nowell J, Blunt E, Edison P.

Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.

Role of TREM2 in the Development of Neurodegenerative Diseases After Traumatic Brain Injury

Zhang C, Chen S.

Mol Neurobiol. 2023 Jan;60(1):342-354. doi: 10.1007/s12035-022-03094-w. Epub 2022 Oct 20.

Challenges in diagnosis and management of delirium in Lewy body disease

Richardson S, Lawson RA, Price A, Taylor JP.

Acta Psychiatr Scand. 2023 May;147(5):475-480. doi: 10.1111/acps.13514. Epub 2022 Nov 4.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias